Metabolomics in the Development and Progression of Dementia: A Systematic Review
Dementia has become a major global public health challenge with a heavy economic burden. It is urgently necessary to understand dementia pathogenesis and to identify biomarkers predicting risk of dementia in the preclinical stage for prevention, monitoring, and treatment. Metabolomics provides a nov...
Main Authors: | Yanfeng Jiang, Zhen Zhu, Jie Shi, Yanpeng An, Kexun Zhang, Yingzhe Wang, Shuyuan Li, Li Jin, Weimin Ye, Mei Cui, Xingdong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.00343/full |
Similar Items
-
Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC‐NCS)
by: Danni Li, et al.
Published: (2016-01-01) -
Untargeted metabolomic profiling of Sphagnum fallax reveals novel antimicrobial metabolites
by: Jane D. Fudyma, et al.
Published: (2019-11-01) -
Characterization of Postprandial Effects on CSF Metabolomics: A Pilot Study with Parallel Comparison to Plasma
by: Kosuke Saito, et al.
Published: (2020-05-01) -
The progress of gut microbiome research related to brain disorders
by: Sibo Zhu, et al.
Published: (2020-01-01) -
The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment
by: Wei-Chieh Weng, et al.
Published: (2019-11-01)